Relapse and Neurological Prognosis in Myelin Oligodendrocyte Glycoprotein Antibody‐Associated Disease: A Retrospective Secondary Analysis of a Japanese Nationwide Epidemiologic Survey

Ähnliche Einträge

• The Japan Neuromyelitis Optica Spectrum Disorders/Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease Registry
  von: Hideyuki Takeuchi, et al.
  Veröffentlicht: (2025)
• The Japan Neuromyelitis Optica Spectrum Disorders/Myelin Oligodendrocyte Glycoprotein Antibody‐Associated Disease Registry: Background Analysis of the Initial 116 Cases
  von: Yusei Miyazaki, et al.
  Veröffentlicht: (2025)
• Effect of Disease‐Modifying Treatments in Japanese Patients With Multiple Sclerosis During the Coronavirus Disease 2019 Pandemic
  von: Taisuke Ogawa, et al.
  Veröffentlicht: (2025)
• Clinical value of the Japanese version of patient‐reported multiple sclerosis neuropsychological screening questionnaire
  von: Atsuya Muryoi, et al.
  Veröffentlicht: (2025)
• Successful Treatment of Refractory Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease With Tocilizumab: A Case Report and Literature Review
  von: Takahiko Katsuyama, et al.
  Veröffentlicht: (2025)